PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
10-Oct-2023 DEFENCE ANNOUNCES PEER-REVIEWED PUBLICATION OF ITS PRECLINICAL DATA ON ACCUM® AS AN ANTI-CANCER MOLECULE IN THE JOURNAL OF CANCER SCIENCE Defence Therapeutics Inc.
10-Oct-2023 Plant Derived Proteins Market to exceed US$ 184.3 Million by 2029: Regional Analysis and Competitive Landscape | FMI MARKITWIRED
10-Oct-2023 Magnetic Resonance Imaging (MRI) Contrast Agents Market to Grow at 4.4% CAGR, Transforming Medical Imaging | FMI MARKITWIRED
10-Oct-2023 Formycon Ranibizumab Biosimilar FYB201/CIMERLI®1 achieved 25% market share2 in the United States Formycon AG
10-Oct-2023 IV Pole Market to Reach US$ 306.1 Million by 2029, Fuelled by Increasing Patient Pool | FMI MARKITWIRED
10-Oct-2023 Skin Tears Treatment Market is projected to grow to US$ 569.4 million by 2029: Revolutionizing Elderly Healthcare | FMI MARKITWIRED
10-Oct-2023 Oscillating Positive Expiratory Pressure (OPEP) Devices Market is expected to reach US$ 195.2 Million by 2029 at CAGR of 5.3% | FMI MARKITWIRED
10-Oct-2023 Cosmo announces submission of Winlevi® to the European Medicines Agency (EMA) Cosmo Pharmaceuticals N.V.
10-Oct-2023 Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone Relief Therapeutics Holding SA
10-Oct-2023 Stool Management Systems Market to Grow at 3.4% CAGR, Reaching US$ 2.5 Billion by 2032 | FMI MARKITWIRED
10-Oct-2023 Transcutaneous Monitors Market is expected to reach US$ 540.1 Million by 2029, Driven by Technological Advancements | FMI MARKITWIRED
10-Oct-2023 Organoids Market to Witness Robust Growth in the Coming Decade, Projected to Reach US$ 205.3 Million by 2033 | FMI MARKITWIRED
10-Oct-2023 Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Businesswire
09-Oct-2023 IQVIA to Announce Third-Quarter 2023 Results on November 1, 2023 Businesswire
09-Oct-2023 Immunis Chairman Dr. Hans Keirstead to Present at Innovative Therapies Days in France Businesswire
09-Oct-2023 IGEA Pharma N.V.: IGEA to update on RBCARE business combination IGEA Pharma N.V.
09-Oct-2023 Oral Antidiabetic Drugs Market to Grasp Outstanding Growth of USD 57 Billion by 2029, Size, Share, Trends, Key Drivers And Growth Opportunities The Wire Times
09-Oct-2023 MaaT Pharma: Increase in Resources Allocated to the Liquidity Contract With the Brokerage Firm Kepler Cheuvreux Businesswire
09-Oct-2023 Quotient Sciences Announces Successful US FDA Inspection of Alnwick, UK Facility Quotient Sciences
09-Oct-2023 EUROAPI: Full-Year 2023 Outlook Revised Downwards Businesswire